SCHEMBL20514940

SCHEMBL20514940

Cn1cc([N+](=O)[O-])cc1C(=O)Nc1cccc(C(=O)Nc2ccc3c(S(=O)(=O)[O-])cccc3c2S(=O)(=O)[O-])c1.[Na+].[Na+]

nearest known ligand 0.80

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPSE Q9Y251 9/20 0.80
KMT2A Q03164 5/20 0.46
POLB P06746 4/20 0.46
MAPT P10636 4/20 0.46
BLM P54132 4/20 0.46
LMNA P02545 3/20 0.46
PKM P14618 3/20 0.46
TSHR P16473 3/20 0.46
NFKB1 P19838 3/20 0.46
APEX1 P27695 3/20 0.46
RECQL P46063 3/20 0.46
HSD17B10 Q99714 3/20 0.46
TDP1 Q9NUW8 3/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP3A4 P08684 2/20 0.46
GAA P10253 2/20 0.46
P2RX1 P51575 2/20 0.46
P2RX3 P56373 2/20 0.46
STAT1 P42224 2/20 0.45
STAT5A P42229 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20514950 0.92 HPSE (0.75) HPSEKMT2APOLBMAPTBLM
SCHEMBL20514980 0.92 HPSE (0.83) HPSEKMT2APOLBMAPTBLM
SCHEMBL20514961 0.90 HPSE (0.79) HPSEKMT2APOLBMAPTBLM
SCHEMBL20514939 0.90 HPSE (0.78) HPSEKMT2APOLBMAPTBLM
SCHEMBL20521771 0.89 HPSE (0.64) HPSEKMT2APOLBMAPTBLM
SCHEMBL20514938 0.85 HPSE (0.91) HPSEKMT2APOLBMAPTBLM
SCHEMBL20514934 0.83 HPSE (0.79) HPSEKMT2APOLBMAPTALDH1A1
SCHEMBL20514941 0.82 HPSE (0.81) HPSEKMT2APOLBMAPTBLM
SCHEMBL11760543 0.82 HPSE (0.57) HPSEKMT2APOLBMAPTBLM
Hydrochloric Acid SCHEMBL20514946 0.82 HPSE (0.72) HPSEKMT2APOLBMAPTBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3381897-A1 DERIVATIVES OF THE DISODIUM 2,2'-{CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(1-METHYL-1H-PYRROLE-4,2-DIYL)CARBONYLIMINO]}DINAPHTHALENE-1,5-DISULFONATE SALT AND RELATED COMPOUNDS AS HEPARANASE INHIBITORS FOR THE TREATMENT OF CANCER Leadiant Biosciences SA (CH) 2018-10-03 EP disclosed